Datasets:
timotheeplanes
/
doping

Dataset card Data Studio Files
xet
 Community
1
text
stringlengths
1
17.8k
Notwithstanding the foregoing, the UCI may elect to conduct Testing during a National Event on Rider s under its Testing authority participating in such Event , including at the Event Venues , with the authorization of the Anti-Doping Organ ization having Testing responsibility for the Event .
Testing Requirements The UCI shall conduct test distribution planning and Testing as required by the UCI Testing & Investigations Regulations.
Where reasonably feasible, Testing shall be coordinated through ADAMS in order to maximize the effectiveness of the combined Testing effort and to avoid unnecessary repetitive Testing .
The UCI Testing & Investigations Regulations are an integral part of these Anti -Doping Rules.
They may b e amended by the UCI from time to time (including upon amendment of the corresponding International Standard or Technical Document by WADA ) and are available in their current version on the UCI Website .
Rider Whereabouts Information The UCI has adopted a ‘pyramid’ or ‘tiered approach’, placing Rider s into different whereabouts pools, referred to as the Registered Testing Pool, Testing Pool and other pool(s), depending upon how much whereabouts information it needs to conduct the amount of Testing allocated to those Rider s. In accordance with the foregoing, four different tiers are established: Tier 1: Rider s included in the UCI Registered Testing Pool (RTP) and therefore required to provide full whereabouts information ; Tier 2: Rider s included in the UCI Testing Pool (TP) and therefore required to provide limited whereabouts information ; Tier 3: Rider s included in the UCI General Pool (GP) and whose whereabouts information is therefore limited to that collected from their Team; Tier 4: Rider s who are not required to provide whereabouts information.
Whereabouts information provided by a Rider will be accessible through ADAMS to WADA and to other Anti-Doping Organizations having authority to test that Rider as provided in Article 5.2.
UCI CYCLING REGULATIONS Page 21 of 70 UCI ADR 2021 Whereabouts information shall be maintained in strict confidence at all times; it shall be used exclusively for purposes of planning, coordinating or conducting Doping Control , providing information relevant to the Athlete Biological Passport or other analytical results, to support an investigation into a potential anti -doping rule violation, or to support proceedings alleging an anti -doping rule violation; and shall be destroyed after it is no longer relevant for these purposes in accordance with the International Standard for the Protection of Privacy and Personal Information.
Registered Testing Pool The UCI shall establish a Registered Testing Pool of those Rider s who are required to provide whereabouts information in the manner specified in the UCI Testing & Investigations Regulations.
Rider s included in the UCI Registered Testing Pool shall be subject to Consequences for Article 2.4 violations (Whereabouts Failure by a Rider ) as provided in Article 10.3.2.
The UCI shall make available through ADAMS and may publish on its website a list which identifies those Rider s included in its Registered Testing Pool by name.
Rider s shall be notified i) when they are included i n the UCI Registered Testing Pool and ii) when they are removed from the UCI Registered Testing Pool as provided for under the UCI Testing & Investigations Regulations.
For purposes of Article 2.4, a Rider ’s failure to comply with the requirements of the UCI Testing & Investigations Regulations shall be deemed a filing failure or a missed test, as defined in Annex B of the UCI Results Management Regulations , where the conditions set forth in Annex B are met .
A Rider in the UCI’s Registered Testing Pool shall continue to be subject to the obligation to comply with the whereabouts requirements and subject to Article 2.4 (Whereabouts Failure by a Rider ) unless and until : (a) the Rider has been given written no tice by the UCI that he/she is removed from the UCI Registered Testing Pool ; or (b) the Rider gives written notice to the UCI of his/her retirement as set forth in the UCI Testing & Investigations Regulations .
[Comment to Article 5.5.1.6: Retirement is effective once the UCI has received the Rider’s written notice of his/her retirement ].
Testing Pool The UCI may, in accordance with the UCI Testing & Investigations Regulations , collect whereabouts information f rom Rider s who are not included within the UCI Registered Testing Pool.
More specifically, the UCI may establish a Testing Pool , which includes Rider s who are subject to less stringent whereabouts requirements than Rider s included in the UCI Registered Testing Pool .
Rider s included in the UCI Testing Pool shall not be subject to Consequences for Article 2.4 violations (Whereabouts Failure by a Rider ) as provided in Article 10.3.2 .
However, a Rider ’s failure to comply with the requirements of the UCI Testing & Investigations Regulations might result in the UCI elevating the Rider to the UCI Registered Testing Pool.
Riders shall be notified i) when they are included in the UCI Testing Pool and ii) when they are removed from the UCI Testing Pool as provided for under the UCI Testing & Investigations Regulations .
UCI CYCLING REGULATIONS Page 22 of 70 UCI ADR 2021 A Rider in the UCI Testing Pool shall continue to be subject to the obligation to comply with the whereabouts requirements unless a nd until (a) the Rider has been given written notice by the UCI that he /she is removed from the UCI Testing Pool ; or (b) the Rider gives written notice to the UCI of his or her retirement as set forth in the UCI Testing & Investigations Regulations .
[Comment to Article 5.5.2.3: Retirement is effective once the UCI has received the Rider’s written notice of his/her retirement ].
UCI Team Whereabouts UCI WorldTeams, UCI ProTeams and UCI Women’s WorldTeams must submit their provisional annual training camp and Competition schedule before the beginning of the next year, including a provisional list of Participants , to the best of their knowledge.
This information shall then be updated on a regular basis and provided upon request.
At a minimum, UCI WorldTeams, UCI ProTeams and UCI Women’s WorldTeams will submit their provisional training camp and Competition schedule for the next year on 15 December and will update it on 15 February, 15 April , 15 June, 15 August, 15 October.
[Comment: When a Team does not know precisely what its training camps/ Competitions schedules or the attendance will be for the upcoming season, it must provide the information to the best of its knowledge and then update t he information on a regular basis.]
Other Teams registered in the UCI (i.e.
other than UCI WorldTeams, UCI ProTeams and UCI Women’s WorldTeams) can also be subject to this obligation upon UCI’s request.
Teams subject to the Team whereabouts obligation unde r this provision shall appoint a person responsible for providing this information in their Team.
In the event the set deadlines are not respected, the Team shall pay a fine of 1000 CHF for each day of delay to the UCI.
In addition, when the delays exceed fifteen ( 15) days, the Team shall, unless circumstances of exceptional nature require otherwise, be suspended from participation in any International Event for a period determined by the UCI Disciplinary Commission .
The suspension shall not be less than fifteen ( 15) days and no more than forty-five ( 45) days.
A reminder shall be sent to the Teams before the expiration of the relevant deadlines indicating the applicable consequences for non -compliance.
Retired Rider s Returning to Competition If a Rider in the UCI Registered Testing Pool retires in accordance with the UCI Testing & Investigations Regulations and then wishes to return to active participation in sport, the Rider shall not compete in Intern ational Events until the Rider has made himself or herself available for Testing , by giving six (6) months prior written notice to the UCI.
WADA , in consultation with the UCI and the Rider 's National Anti -Doping Organization , may grant an exemption to the six (6) month written notice rule where the strict application of that rule would be unfair to the Rider .
This decision may be appealed under Article 13.
[Comment to Article 5.
6.1: WADA has developed a protocol and exemption application form that Rider s must use to make such requests, and a decision template that the UCI must use.
Both documents are available on WADA ’s website.]
UCI CYCLING REGULATIONS Page 23 of 70 UCI ADR 2021 Any competitive results obtained in violation of this Article 5.6.1 shall be Disqualified , unless t he Rider can establish that he or she could not have reasonably known that this was an International Event .
If a Rider retires from sport while subject to a period of Ineligibility , the Rider must notify the Anti-Doping Organization that imposed the perio d of Ineligibility in writing of such retirement.
If the Rider then wishes to return to active competition in sport, the Rider shall not compete in International Events or National Events until the Rider has made himself or herself available for Testing by giving six (6) months prior written notice (or notice equivalent to the period of Ineligibility remaining as of the date the Rider retired, if that period was longer than six (6) months) to the UCI.
Investigation and Intelligence Gathering The UCI shall ensure that it has the capability to conduct investigation s and gather intelligence as required by the UCI Testing & Investigations Regulations.
Independent Observer Program The UCI and the organizing committees for the UCI’s Events , as well as the National Federations and the organizing committees for National Events, shall authorize and facilitate the Independent Observer Program at such Events .
ANALYSIS OF SAMPLES Samples shall be analyzed in accordance with the following principles: Use of Accredited, Approved Laboratories and Other Laboratories For purposes of directly establishing an Adverse Analytical Finding under Article 2.1, Samples shall be analyzed only in WADA -accredit ed laboratories or laboratories otherwise approved by WADA .
The choice of the WADA -accredited or WADA -approved laboratory used for the Sample analysis shall be determined exclusively by the UCI.
As provided in Article 3.2, facts related to anti -doping rule violations may be established by any reliable means.
This would include, for example, reliable laboratory or other forensic testing conducted outside of WADA -accredited or approved laboratories.
[Comment to Article 6.1: Violations of Article 2.1 may be established only by Sample analysis performed by a WADA -accredited laboratory or another laboratory approved by WADA .
Violations of other Articles may be established using analytical results from other laboratories so long as the results are reliable.]
Purpose of Analysis of Samples and Data Samples and related analytical data or Doping Control information shall be analyzed to detect Prohibited Substances and Prohibited Methods identified on the Prohibited List and other substances as may be directed by WADA pursuant to the monitoring program described in Article 4.5, or to assist the UCI in profiling relevant parameters in an Rider ’s urine, blood or other matrix, including for DNA or genomic profil ing, or for any other legitimate anti -doping purpose.
Samples may be collected and stored for future further analysis and/or reanalysis.
[Comment to Article 6.2: For example, relevant Doping Control -related information could be used to direct Target Testing or to support an anti -doping rule violation proceeding under Article 2.2, or both.]
Research on Samples and Data Samples , related analytical data and Doping Control information may be used for anti -doping research purposes, although no Sampl e may be used for research without the Rider 's written consent.
Samples and related analytical data or Doping Control information used for research purposes shall first be processed in such a manner as to prevent Samples and related analytical data or Doping Control information being traced back to a particular Rider .
Any research involving UCI CYCLING REGULATIONS Page 24 of 70 UCI ADR 2021 Samples and related analytical data or Doping Control information shall adhere to the principles set out in Article 19 of the Code .
[Comment to Article 6.3: As is the case in most medical or scientific contexts, use of Samples and related information for quality assurance, quality improvement, method improvement and development or to establish reference populations is not considered re search.
Samples and related information used for such permitted non -research purposes must also first be processed in such a manner as to prevent them from being traced back to the particular Rider , having due regard to the principles set out in Article 19 of the Code , as well as the requirements of the International Standard for Laboratories and International Standard for the Protection of Privacy and Personal Information.]
Standards for Sample Analysis and Reporting WADA accredited L aboratories shall analyze Samples and reports results in conformity with the International Standard for Laboratories.
Laboratories at their own initiative and expense may analyze Samples for Prohibited Substances or Prohibited Methods not included on the standard Sample analysis menu, or as requested by the UCI.
Results from any such analysis shall be reported to the UCI and have the same validity and Consequences as any other analytical result .
[Comment to Article 6.4: The objective of this Article is to extend the princi ple of “Intelligent Testing” to the Sample analysis menu so as to most effectively and efficiently detect doping.
It is recognized that the resources available to fight doping are limited and that increasing the Sample analysis menu may, in some sports and countries, reduce the number of Samples which can be analyzed.]
Further Analysis of a Sample Prior to or During Results Management or Hearing Process There shall be no limitation on the authority of a laboratory to conduct repeat or additional analysis on a Sample prior to the time the UCI notifies a Rider that the Sample is the basis for an Article 2.1 anti -doping rule violation charge.
If after such notification the UCI wishes to conduct additional analysis on that Sample , it may do so with the consent of the Rider or approval from a hearing body .
Further Analysis of a Sample After it has been Reported as Negative or has Otherwise not Resulted in an Anti -Doping Rule Violation Charge After a laboratory has reported a Sample as negative, or the Sample has not otherwise resulted in an anti -doping rule violation charge, it may be stored and subjected to further analyses for the purpose of Article 6.2 at any time exclusively at the direction of either the Anti-Doping Organization that initiated and directed Sample collection or WADA .
Any other Anti-Doping Organization with authority to test the Rider that wishes to conduct further analysis on a stored Sample may do so with the permission of the Anti-Doping Organization that initiated and directed Sample collection or WADA , and shall be responsible for any follow -up Results Management .
Any Sample storage or further analysis initiated by WADA or another Anti-Doping Organization shall be at WADA ’s or that organization's expense.
Further analysis of Samples shall conform with the requirements of the International Standa rd for Laboratories.
Split of A or B Sample Where WADA , an Anti-Doping Organization with Results Management authority, and/or a WADA -accredited laboratory (with approval from WADA or the Anti-Doping Organization with Results Management authority) wishes to split an A or B Sample for the purpose of using the first part of the split Sample for an A Sample analysis and the second part of the split Sample for confirmation, then the procedures set forth in the International Standard for Labo ratories shall be followed.
UCI CYCLING REGULATIONS Page 25 of 70 UCI ADR 2021 Ownership of Samples Samples collected from a Rider under these Anti -Doping Rules are owned by the UCI.
The UCI may transfer ownership of the Samples to another Anti-Doping Organization or receive ownership of Samples from other Anti-Doping Organizations , upon request.
WADA ’s Right to Take Possession of Samples and Data WADA may, in its sole discretion at any time, with or without prior notice, take physical possession of any Sample and related analytical data or information in the possession of a laboratory or Anti-Doping Organization .
Upon request by WADA , the laboratory or Anti-Doping Organization in possession of the Sample or data shall immediately grant access to and enable WADA to take physical possession of the Sample or data .
If WADA has not provided prior notice to the laboratory or Anti-Doping Organization before ta king possession of a Sample or data , it shall provide such notice to the laboratory and each Anti-Doping Organization whose Samples or data have been taken by WADA within a reasonable time after taking possession.
After analysis and any investigation of a seized Sample or data , WADA may direct another Anti-Doping Organization with authority to test the Rider to assume Results Management responsibility for the Sample or data if a potential anti -doping rule violation is discovered.
[Comment to Article 6.
9: Resistance or refusal to WADA taking physical possession of Samples or data could constitute Tampering, Complicity or an act of non -compliance as provided in the International Standard for Code Compliance by Signatories, and could also constitute a viola tion of the International Standard for Laboratories.
Where necessary, the laboratory and/or the Anti -Doping Organization shall assist WADA in ensuring that the seized Sample or data are not delayed in exiting the applicable country.
WADA would not, of cour se, unilaterally take possession of Samples or analytical data without good cause related to a potential anti -doping rule violation, non -compliance by a Signatory or doping activities by another Person.
However, the decision as to whether good cause exists is for WADA to make in its discretion and shall not be subject to challenge.
In particular, whether there is good cause or not shall not be a defense against an anti -doping rule violation or its Consequences.]
Costs of Testing and Analysis The costs of In-Competition Testing initiated and directed by the UCI shall be borne by the organizer of the Event .
The costs of Out-of-Competition Testing directed by the UCI shall be borne by the UCI.
The costs of Out-of-Competition Testing directed by a National Fed eration so authorized at its request shall be borne by that National Federation .
The ultimate allocation of Testing and Sample analysis costs shall be as set forth in Article 10.1 2.
RESULTS MANAGEMENT & INVESTIGATIONS Responsibility for Conducting Results Management Except as otherwise provided in Articles 6.6, 6.
9 and Article 7.1, Results Management shall be the responsibility of, and shall be governed by, the procedural rules of the Anti-Doping Organization that init iated and directed Sample collection (or, if no Sample collection is involved, the Anti-Doping Organization which first provides notice to a Rider or other Person of a potential anti-doping rule violation and then diligently pursues that anti -doping rule v iolation).
General Responsibility of the UCI The UCI shall have responsibility for Results Management conducted under these Anti -Doping Rules as follows, subject to Articles 7.1.2 , 7.1.3 and 7.1.4. below: a) For potential violations arising in connection with Testing conducted by the UCI under these Anti -Doping Rules, including investigations against Rider Support Personnel or other Persons potentially involved in such violations; UCI CYCLING REGULATIONS Page 26 of 70 UCI ADR 2021 [Comment: violations arising in connection with Testing shall include, without limitation, Article 2.1, 2.2 (where the violation is based on Test results), 2.3 or 2.5] b) For potential violation of these Anti -Doping Rules where no Testing is involved and where the following apply: either: i) for all violations involving International -Level Rider s, Rider Support Personnel or other Persons who have an involvement in any capacity in International Events or with International -Level Rider s; or: ii) for all violations occurring in connection with - or discovered on the occasion of - an International Event ; but only where the UCI is the Anti-Doping Organization which first provides notice to a Rider , Rider Support Personnel or other Person of an asserted anti -doping rule violation and then diligently pursues that anti -doping rule violation.
Default Responsibility of the UCI as an International Federation In circumstances where the rules of a National Anti -Doping Organization do not give the National Anti -Doping Organization authority over a Rider or other Person who is not a national, resident, licence holder or member of a sport organization of that country, or the National Anti -Doping Organization declines to exercise such authorit y, Results Management shall be conducted by the UCI or by a third party with authority over the Rider or other Person as directed by the se Anti -Doping Rules .
In the event a Major Event Organization assumes only limited Results Management responsibility rel ating to a Sample initiated and taken during an Event conducted by a Major Event Organization , or an anti -doping rule violation occurring during such Event , the case shall be referred by the Major Event Organization to the UCI for completion of Results Management .
[Comment to Article 7.1.2.2: T he Major Event Organization for that Event shall assume Results Management responsibility to at least the limited extent of conducting a hearing to determine whether an anti-doping rule v iolation was committed and, if so, the applicable Disqualifications under Articles 9 and 10.1, any forfeiture of any medals, points, or prizes from that Event, and any recovery of costs applicable to the anti -doping rule violation. ]
WADA may direct the UCI to conduct Results Management in particular circumstances.
If the UCI refuses to conduct Results Management within a reasonable deadline set by WADA , such refusal shall be considered an act of non -compliance, and WADA may direct another Anti-Doping Organi zation with authority over the Rider or other Person , that is willing to do so, to take Results Management responsibility in place of the UCI or, if there is no such Anti-Doping Organization , any other Anti-Doping Organization that is willing to do so.
In such case, the UCI shall reimburse the costs and attorney fees of conducting Results Management to the other Anti-Doping Organization designated by WADA , and a failure to reimburse costs and attorney’s fees shall be considered an act of non -compliance.
UCI CYCLING REGULATIONS Page 27 of 70 UCI ADR 2021 Responsibilities in Specific Circumstances Results Management in relation to a potential whereabouts failure (a filing failure or a missed test) and , where applicable, to a potential violation under Article 2.4 shall be administered by the UCI if the Rider in question files his or her whereabouts information with the UCI, as provided in the UCI Results Management Regulations.
The Anti-Doping Organization that determines a filing failure or a missed test shall submit that information to WADA through ADAMS , where it will be made available to other relevant Anti-Doping Organizations .
Results Management for Adverse Passport Findings or Atypical Passport Findings and related review shall be conducted by the UCI if the UCI is the Rider ’s passport custodian .
Where a National Anti -Doping Organization elects to collect additional Samples pursuant to Article 5.2.
4, then it shall be considered the Anti-Doping Organization that initiated and directed Sample collection.